🔍 Observations
Topline
- Revenue from operations surged 30% YoY (₹6,760M → ₹8,762M), with product sales the primary driver, jumping 30% (₹6,646M → ₹8,654M).
- Q4 FY26 revenue of ₹3,061M was 67% higher than Q4 FY25 (₹1,831M) — strongest quarter of the year, confirming an accelerating demand curve.
- Other income spiked to ₹231M (vs ₹52M in FY25), largely from mutual fund fair value gains (₹86M) — non-recurring and should be stripped for core analysis.
Bottomline
- Net profit nearly doubled YoY: ₹529M → ₹940M (+78%), driven by operating leverage and revenue scaling.
- Q4 FY26 PAT of ₹443M is 3.2x Q4 FY25 (₹139M), demonstrating steep sequential and annual profit acceleration.
- Effective tax rate improved slightly (26.1% in FY26 vs 26.1% in FY25), neutral contribution to profit growth.
Margins
- EBITDA (PBT + Finance Costs + D&A): FY26 = ₹1,299M + ₹294M + ₹350M = ₹1,943M on revenue of ₹8,762M → EBITDA margin: 22.2% vs FY25: ₹715M + ₹222M + ₹322M = ₹1,259M on ₹6,760M → 18.6%. ~360bps margin expansion YoY.
- Net profit margin: ₹940M / ₹8,762M = 10.7% vs ₹529M / ₹6,760M = 7.8% — 290bps improvement.
- Employee costs as % of revenue: 17.2% (FY26) vs 18.3% (FY25) — operating leverage on fixed-cost workforce base is materialising.
Growth Trajectory
- Revenue CAGR implied on a 2-year base (FY25 vs FY26) is strong; the Q4 trajectory suggests FY27 could open well above ₹3,000M/quarter run-rate.
- Inventory build (₹3,461M → ₹5,005M, +45%) and large advances received (other current liabilities ₹445M → ₹2,549M, +473%) suggest a robust order book being prepped for execution.
- The scale-up appears demand-led rather than speculative — advance receipts of ₹2,549M signal confirmed customer commitments.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- 78% PAT growth on 30% revenue growth — operating leverage is working; fixed-cost absorption improving materially.
- EBITDA margin expansion of ~360bps (18.6% → 22.2%) signals structural efficiency gains, not just revenue tailwinds.
- Q4 FY26 PAT of ₹443M = 47% of full-year FY26 PAT — exit momentum heading into FY27 is exceptionally strong.
- Other current liabilities up ₹2,104M YoY (predominantly customer advances) — signals a deep, funded order pipeline reducing revenue visibility risk.
- Operating cash flow of ₹1,969M vs ₹1,013M in FY25 — near-doubling of OCF confirms earnings quality is improving alongside reported profits.
- Capex sustained at ₹1,336M (vs ₹1,283M in FY25) — capacity investment continues without over-stretching; management is pacing growth responsibly.
- Employee cost leverage (17.2% of revenue vs 18.3%) demonstrates the business can scale revenue faster than headcount costs.
🔴 Red Flags
- Total borrowings jumped from ₹1,773M to ₹3,692M (+108%) in one year — debt has more than doubled; interest coverage needs monitoring as finance costs rose to ₹294M.
- Trade receivables up 61% (₹2,098M → ₹3,368M) against 30% revenue growth — receivables are growing 2x faster than sales, raising collection cycle concerns.
- Inventory up 45% (₹3,461M → ₹5,005M) — even accounting for the order book build, this represents significant working capital lock-up.
- Free cash flow is deeply negative: OCF ₹1,969M minus capex ₹1,336M minus mutual fund outflows ₹2,150M = net investing outflow of ₹3,526M, funded entirely by ₹1,548M of new borrowings.
- Cash & cash equivalents collapsed to ₹10M (from ₹19M) — the company is essentially operating with zero liquidity buffer; mutual fund holdings of ₹2,153M serve as the real cash proxy but carry market risk.
- Other income of ₹231M includes ₹86M fair value gains on mutual funds — inflates reported PBT; strip this and reported margin optically compresses.
- Labour Code provision of ₹37.67M (exceptional item) — one-time hit but signals regulatory compliance costs being recognised belatedly.
📊 Balance Sheet Analysis
- Leverage has risen sharply: Debt-to-equity moved from ~0.24x (₹1,773M / ₹7,289M) to ~0.45x (₹3,692M / ₹8,226M) — still manageable but trending in the wrong direction given working capital financing is driving a significant portion of borrowings.
- Asset quality is reasonable: PPE of ₹4,972M is productive capex; CWIP has reduced (₹532M → ₹344M), indicating assets are being commissioned and not idling.
- Current ratio: Current assets ₹11,282M / Current liabilities ₹7,268M = 1.55x — adequate, but the quality is mixed with ₹5,005M in inventory and receivables being the bulk of current assets.
- Net worth grew: Equity increased from ₹7,289M to ₹8,226M via retained earnings — book value is being built organically, which is a positive signal for long-term solvency.
💰 Cash Flow Analysis
- OCF of ₹1,969M is strong and nearly 2.1x earnings (₹940M) — high quality; the key driver is the massive ₹2,107M increase in other current liabilities (customer advances), effectively client-funded operations.
- Investing outflows of ₹3,526M dominated by ₹2,150M mutual fund deployment — this is surplus cash being parked, not a business investment; stripping it, core capex was ₹1,336M and FCF = ₹633M, which is positive.
- Financing inflows of ₹1,548M reflect net borrowing increase of ~₹1,920M offset by repayments and lease costs — debt is being used to fund the working capital cycle (receivables + inventory build).
- Net cash position is illusory: Reported cash of ₹10M masks ₹2,153M in liquid mutual funds — the company manages liquidity actively through market instruments rather than bank balances.
💡 Investment Outlook
MTAR Technologies is executing a high-quality revenue ramp — 30% topline growth with 360bps EBITDA margin expansion and near-doubling of PAT signals genuine operating leverage in a capital-intensive precision manufacturing business.
The ₹2,549M in customer advances reflects a robust, funded order book that de-risks near-term revenue visibility significantly.
However, the concurrent doubling of debt, 61% receivables growth, and deeply negative headline FCF (before adjusting for MF parking) warrant close monitoring — if collection cycles slip or order execution delays, the working capital burden could tighten quickly.
Investors should track receivable DSO and debt trajectory over the next 2 quarters to confirm this is a controlled scale-up and not a leverage-driven earnings story.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.